iANTHUS CAPITAL HOLDINGS (ITHUF) Other Non-Current Assets (2020 - 2026)

iANTHUS CAPITAL HOLDINGS's (ITHUF) quarterly Other Non-Current Assets came in at $3.1 million in Q1 2026, down 81.27% year-on-year from $16.3 million in Q1 2025, and down 4.77% quarter-over-quarter from $3.2 million in Q4 2025.

iANTHUS CAPITAL HOLDINGS (ITHUF) Other Non-Current Assets (2020 - 2026) Analysis & Trends

iANTHUS CAPITAL HOLDINGS has disclosed Other Non-Current Assets across 7 years of filings, most recently posting $3.1 million for Q1 2026.

  • Other Non-Current Assets for Q1 2026 came in at $3.1 million, down 81.27% year-over-year; the trailing twelve-month figure through Mar 2026 was $3.1 million (down 81.27% YoY), and the FY2025 annual result was $3.2 million, down 36.23% from the prior year.
  • Other Non-Current Assets came in at $3.1 million for Q1 2026 at iANTHUS CAPITAL HOLDINGS, down from $3.2 million in the prior quarter.
  • In the past five years, Other Non-Current Assets ranged from a high of $16.3 million in Q1 2025 to a low of $3.1 million in Q1 2026.
  • The 5-year median for Other Non-Current Assets is $3.9 million (2022), against an average of $5.3 million.
  • Across the five-year window, Other Non-Current Assets surged 272.02% in 2025 and plunged 81.27% in 2026, its largest moves.
  • iANTHUS CAPITAL HOLDINGS's Other Non-Current Assets stood at $3.8 million in 2022, then grew by 14.66% to $4.4 million in 2023, then increased by 14.08% to $5.0 million in 2024, then sank by 36.23% to $3.2 million in 2025, then fell by 4.77% to $3.1 million in 2026.
  • The last three Other Non-Current Assets figures came in at $3.1 million (Q1 2026), $3.2 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 1.79 Bn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn 351.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 233.20 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn 3.45 Mn
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn 73.60 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn 295.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn 59.36 Mn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn 47.63 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn -
10 iANTHUS CAPITAL HOLDINGS - - 15.92 Mn 3.06 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 3.06 Mn
Dec 31, 2025 3.21 Mn
Sep 30, 2025 3.40 Mn
Jun 30, 2025 14.90 Mn
Mar 31, 2025 16.31 Mn
Dec 31, 2024 5.03 Mn
Sep 30, 2024 4.92 Mn
Jun 30, 2024 4.32 Mn
Mar 31, 2024 4.39 Mn
Dec 31, 2023 4.41 Mn
Sep 30, 2023 3.81 Mn
Jun 30, 2023 3.83 Mn
Mar 31, 2023 3.84 Mn
Dec 31, 2022 3.85 Mn
Sep 30, 2022 3.85 Mn
Jun 30, 2022 3.90 Mn
Mar 31, 2022 3.90 Mn
Dec 31, 2021 8.65 Mn
Sep 30, 2021 8.44 Mn
Jun 30, 2021 8.15 Mn